Table 4. Antimicrobial resistance pattern of ESBL producing and non-ESBL producing E. coli and K. pneumoniae isolates.
| Antimicrobial Agents | ESBL producing | Non -ESBL producing | Total (N = 263) | |||
|---|---|---|---|---|---|---|
| E. coli (N = 39) | K. pneumonia (N = 8) | Total | E. coli (N = 185) | K. pneumonia (N = 31) | ||
| Resistance | Resistance | Resistance | Resistance | Resistance | ||
| Ampicillin | 37(94.9) | 8(100) | 45(95.7) | 127(68.6) | 31(100) | 203(77.2) |
| Amoxicillin/Clavulanic Acid | 17(43.6) | 2(25) | 19(40.4) | 50 (27.0) | 3 (9.7) | 72(27.3) |
| Ampicillin/Sulbactam | 30(76.9) | 6(75.5) | 36(76.5) | 101 (54.6) | 10(32.3) | 147(55.8) |
| Cefazolin | 29(74.4) | 7(87.5) | 36(76.6) | 23 (12.4) | 1 (3.2) | 60(22.8) |
| Cefuroxime | 34(87.2) | 7(87.5) | 41(87.2) | 16 (8.6) | 0(0) | 57(21.7) |
| Cefuroxime Axetil | 37(94.9) | 7(87.5) | 44(93.6) | 22 (11.9) | 1 (3.2) | 67(25.7) |
| Ceftazidime | 28(71.8) | 7(87.5) | 35(74.5) | 0 (0) | 0(0) | 35(13.3) |
| Ceftriaxone | 29(74.4) | 7(87.5) | 36(76.6) | 0(0) | 0(0) | 36(13.7) |
| Cefepime | 29(74.4) | 7(87.5) | 36(76.6) | 0(0) | 0(0) | 36(13.7) |
| Ertapenem | 0(0.0) | 0(0.0) | 0(0.0) | 0(0) | 0(0) | 0(0) |
| Imipenem | 0(0.0) | 0(0.0) | 0(0.0) | 0(0) | 0(0) | 0(0) |
| Gentamicin | 4(10.3) | 4(50.0) | 8(17.0) | 1 (0.5) | 1 (3.2) | 10(3.8) |
| Tobramycin | 7(18.0) | 5(62.5) | 12(25.5) | 2 (1.0) | 1 (3.2) | 15(5.7) |
| Ciprofloxacin | 10(25.6) | 2(25.0) | 12 (25.5) | 3 (1.5) | 0(0) | 15(5.7) |
| Levofloxacin | 9(23.1) | 1(12.5) | 10(21.3) | 3 (1.6) | 0(0) | 13(4.9) |
| Tetracycline | 29(74.4) | 4(50.0) | 33(70.2) | 105(56.7) | 13 (41.9) | 151(57.4) |
| Nitrofurantoin | 8(20.5) | 4(50.0) | 12(25.5) | 7(3.7) | 1 1(35.5) | 30(11.4) |
| Trimethoprim/Sulfemethoxazole | 32(82.1) | 5(62.5) | 37(78.7) | 110(59.5) | 13(41.9) | 160(60.8) |